Plants and microorganisms, being the major source of many drugs, have attracted scientists from ancient times. However, until recently an insignificant part of the plants and some microorganisms have scientifically been evaluated for their medicinal values. The present study was undertaken to discover new drug candidates from natural sources. Extensive chemical studies with 60 medicinal plants and several microbial strains of Bangladesh have resulted in the isolation and characterization of 150 compounds, including 50 new molecules. Terpenoids and alkaloids were the major constituents among the isolated compounds. The crude extractives and several purified molecules demonstrated statistically significant inhibition of growth of microorganisms, antioxidant, antidiabetic and HIV-inhibitory activities. Usnic acid, a lead compound isolated from the lichen, Parmelia kamtschandalis, showed potent antimicrobial activity, whereas dehydroaltenusin obtained from a Streptomyces sp. exhibited significant HIV-inhibitory effects.
Introduction
Medicinal plants are the blessings for any country which contribute a lot for traditional health management as well as providing lead compounds for modern drug discovery. The varieties of molecules contained in plants have been proved to combat complicated diseases. Based on this, natural product scientists have always focused on the isolation of bioactive compounds from these precious herbs and trees. In addition, the giant pharmaceutical companies are also capitalizing these scopes for incorporating new drugs in the market (Burnett et al., 2012; Christen and Cuendet, 2012; Hung et al., 2012; Lovkova et al., 2001 and Cragg, 2012) .
Bangladesh being a subtropical country is a good repository of plants. There are around 5000 angiosperms distributed among 200 families. Approximately, 500 of these are being used in the traditional medicines for the treatment of different types of diseases. A significant percentage of the population depends on the natural product based medicines. In addition, the total medicinal plant market of Bangladesh is equivalent to US$14 billion each year. As part of our continuing studies on plants here, we summarize the chemistry and bioactivities of some of the isolated constituents from 48 medicinal plants of Bangladesh (Ara et al., 2006; Begum et al., 2011; Islam et al., 2009; Jahan et al., 2009 and Rahman et al., 2011) .
Materials and Methods

Chemical:
The chemical investigation of a plant involved collection and prop er identification of the plant materials, extraction, fractionation and purification of compounds and structural characterization of the purified secondary metabolites. On the other hand, the culture filtrate of the microorganism's broth culture was extracted with ethyl acetate. Various chromatographic techniques (Zhu et al., 2003; Moustafa et al., 2007; Widodo et al., 2008 and Jain and Bari, 2010) were utilized for isolation and purification of the compounds from the extractives. The structures of the purified compounds were determined by extensive analyses of UV, IR, NMR and mass spectroscopic data as well as by chemical derivatization, when needed. Whenever possible, the crude extracts, fractions and purified compounds were subjected to bioassays (e.g. antimicrobial activity, antioxidant, antidiabetic, HIV inhibitory activities etc.) The whole process can be explained by scheme 1.
Antimicrobial activity:
The antimicrobial activity of the purified compounds (Bhilabutra et al., 2007; Ahamed et al., 2007 and Ghani et al., 2012) was determined by the disc diffusion method (Sunilson et al., 2009) . The bacterial strains were collected as pure cultures from the Institute of Nutrition and Food Science (INFS), University of Dhaka, Bangladesh. The samples were dissolved separately in chloroform and applied to sterile discs at 100 or 30 µg/ disc and carefully dried to evaporate the residual solvent. Here, kanamycin, amoxicillin, streptomycin and tetracycline were used as standard antimicrobial agents. Scheme 1. Isolation, purification and bioassay of compounds.
Antioxidant activity:
The antioxidant (free radical scavenging) activity of the compounds was assessed by the method of Brand-Williams (Brand-Williams et al., 1995; Aher et al., 2009 and Ham et al., 2010) . Percentage inhibitions were plotted against respective concentrations used and from the graph obtained, the IC 50 was calculated. Tert-butyl-1-hydroxytoluene (BHT), a potential antioxidant, was used as positive control.
Antidiabetic activity: Antidabetic activity was investigated on alloxan-induced Long Evan's rats following the procedure published elsewhere (Mansour et al., 2002) . The rats (weighing 100-200 g were used for the study) were obtained from international Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B), Dhaka. The experimental procedure is shown in Table 1 .
Anti-HIV assay:
The purified compound was dissolved in DMSO, diluted to the desired concentration and tested in a XTT-based in vitro anti-HIV assay (Gulakowski et al., 1991) . (Rahman et al., 2001) . The structures of these compounds were elucidated by extensive spectroscopic studies including 2D NMR and MS and chemical derivatization wherever needed. The structures of some of the isolated compounds are shown below: 1-Methyl-7-methoxy-β-carboline 7-Hydroxy-beta carboline-1-propionic acid
Sesquiterpenes from
Biological:
The crude plant extracts and purified compounds were subjected to screening for antimicrobial, antioxidant, anti-diabetic and anti-HIV activities. The results of some of the assays are summarized in the following tables:
Biological: i) Antimicrobial activity: Table 2 . Antimicrobial activity of Garuganin V from Garuga pinnata at 100 μg/disc (Ara et al., 2012).
Microbes
Diameter of zone of inhibition (mm) Structure (sample) Garuganin V Kanamycin
Gram positive bacteria
Garuganin V
Bacillus cereus 40 21
Staphylococcus aureus 35 23
Gram negative bacteria
Escherichia coli 32 23
aVibrio mimicus 36 21
Fungus
Aspergillus niger 31 20
Candida albicans 35 20 iii) Antidiabetic activity: The glucose level obtained in the blood of normal and experimental rats are given in table 5 for E. prostrata extract and in table 6 for eclalbasaponin II. The safety of the extractives in animal was evaluated by observing the effects of the extractives on liver enzymes. The levels of enzymes, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) in plasma of normal and diabetic rats are depicted in table-8. The plant extract treated animals showed no significant changes of these enzyme levels as compared to the normal rats. This suggested that the extractives were safe in rat models. However, the levels of these enzymes were much lower than the diabetic control rats receiving no drugs.
The methanolic extract (300 mg/kg) showed a significant (P<0.05) blood glucose reduction (14.50%) on 7th day in diabetic rats as compared to the untreated diabetic rats (Table 6 ). Consequently, serum sugar reducing activity became significant (P<0.001) after 21 (43.18%) and 28 days (48.38%) of drug treatment. The purified compound, eclalbasaponin II (10 mg/kg) also reduced the serum sugar level (16.07%) significantly (P<0.001) after 3 days of treatment when compared with the untreated diabetic rats. The blood sugar lowering effects were increased after 5 (36.53%) and 7 days (52.90%) by eclalbasaponin II. In alloxan-induced diabetic rats the levels of plasma AST, ALT and ALP were significantly (P<0.001) increased by 93.48%, 64.30% and 81.44%, respectively relative to their normal levels in rats (Table 8) . On the other hand, treatment of the diabetic rats with methanolic extract of the E. prostrata caused a reduction in the activity 43.74%, 37.97% and 48.09% of ALT, AST and ALP in blood plasma as compared to the mean values in the diabetic rats. It was also observed that there was no significant difference in the liver enzyme levels between the normal, glibenclamide and E. prostrata treated rats. Therefore, the herb did not have any hepatotoxicity on rats . Similar hypoglycemic activity has been reported for glycoside D (β-D-galactopyranosyl) from Calendula officinalis (Fam.-Compositae) (Yoshikawa et al., 2001) . Glycoside D and eclalbasaponin II are structurally related, both of which have been obtained from the member of the same family. Values are given as mean ± SEM for 6 rats in each group. Diabetic control (Group-2) was compared with normal (Group-1) on corresponding day; Experimental group (Group-4) was compared with diabetic control group on corresponding day; *P<0.05; **P<0.001 Values are given as mean ± SEM for 6 rats in each group. Diabetic control (Group-2) was compared with normal (Group-1). Experimental group (Group-4) was compared with diabetic control (Group-2). **P<0.001
Anti-HIV activity: The anti-HIV activity of dehydroaltenusin from Streptomyces sp. (Jabbar et al., 1999 
Conclusion
A total of 60 plant species have been investigated. Many structurally unique and diversified compounds having interesting biological activities were isolated from these plants. Our studies show that Bangladeshi plants can be a promising source of novel drug candidates.
